These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23859623)

  • 21. Storage of neural histamine and histaminergic neurotransmission is VMAT2 dependent in the zebrafish.
    Puttonen HAJ; Semenova S; Sundvik M; Panula P
    Sci Rep; 2017 Jun; 7(1):3060. PubMed ID: 28596586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel optical tracer for VMAT2 applied to live cell measurements of vesicle maturation in cultured human β-cells.
    Pecic S; Milosavic N; Rayat G; Maffei A; Harris PE
    Sci Rep; 2019 Apr; 9(1):5403. PubMed ID: 30932004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.
    Eiden LE; Weihe E
    Ann N Y Acad Sci; 2011 Jan; 1216():86-98. PubMed ID: 21272013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons.
    Henke A; Kovalyova Y; Dunn M; Dreier D; Gubernator NG; Dincheva I; Hwu C; Šebej P; Ansorge MS; Sulzer D; Sames D
    ACS Chem Neurosci; 2018 May; 9(5):925-934. PubMed ID: 29281252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrrolidine analogs of GZ-793A: synthesis and evaluation as inhibitors of the vesicular monoamine transporter-2 (VMAT2).
    Penthala NR; Ponugoti PR; Nickell JR; Deaciuc AG; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3342-5. PubMed ID: 23597792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines.
    Wang Y; Zhang P; Chao Y; Zhu Z; Yang C; Zhou Z; Li Y; Long Y; Liu Y; Li D; Wang S; Qu Q
    Cell Res; 2024 Jan; 34(1):47-57. PubMed ID: 38163846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.
    Lohr KM; Stout KA; Dunn AR; Wang M; Salahpour A; Guillot TS; Miller GW
    ACS Chem Neurosci; 2015 May; 6(5):790-9. PubMed ID: 25746685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines.
    Li H; Waites CL; Staal RG; Dobryy Y; Park J; Sulzer DL; Edwards RH
    Neuron; 2005 Nov; 48(4):619-33. PubMed ID: 16301178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals.
    Lohr KM; Chen M; Hoffman CA; McDaniel MJ; Stout KA; Dunn AR; Wang M; Bernstein AI; Miller GW
    Toxicol Sci; 2016 Sep; 153(1):79-88. PubMed ID: 27287315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].
    Lorenzo-Sanz G; Sánchez-Herranz A
    Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
    Vergo S; Johansen JL; Leist M; Lotharius J
    Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways.
    Onoa B; Li H; Gagnon-Bartsch JA; Elias LA; Edwards RH
    J Neurosci; 2010 Jun; 30(23):7917-27. PubMed ID: 20534840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1 neurons in the rat rostral ventrolateral medulla differentially express vesicular monoamine transporter 2 in soma and axonal compartments.
    Sevigny CP; Bassi J; Teschemacher AG; Kim KS; Williams DA; Anderson CR; Allen AM
    Eur J Neurosci; 2008 Oct; 28(8):1536-44. PubMed ID: 18973576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2.
    Kilbourn MR; Koeppe RA
    ACS Chem Neurosci; 2019 Jan; 10(1):25-29. PubMed ID: 30198706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine.
    Horton DB; Nickell JR; Zheng G; Crooks PA; Dwoskin LP
    J Neurochem; 2013 Oct; 127(2):177-86. PubMed ID: 23875622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
    Eyerman DJ; Yamamoto BK
    J Neurochem; 2007 Nov; 103(3):1219-27. PubMed ID: 17683483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deuterated
    Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vesicular monoamine transporter 2: role as a novel target for drug development.
    Zheng G; Dwoskin LP; Crooks PA
    AAPS J; 2006 Nov; 8(4):E682-92. PubMed ID: 17233532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of vesicular monoamine transporter 2 in epileptic patients and experimental rats.
    Jiang G; Cao Q; Li J; Zhang Y; Liu X; Wang Z; Guo F; Chen Y; Chen Y; Chen G; Wang X
    Synapse; 2013 Jul; 67(7):415-26. PubMed ID: 23504951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.